These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Zhang LB; Buxton IL Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840 [TBL] [Abstract][Full Text] [Related]
3. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons. Eva C; Gamalero SR; Genazzani E; Costa E J Pharmacol Exp Ther; 1990 Apr; 253(1):257-65. PubMed ID: 2158546 [TBL] [Abstract][Full Text] [Related]
5. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis. Masters SB; Quinn MT; Brown JH Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182 [TBL] [Abstract][Full Text] [Related]
6. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Fisher SK Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells. Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M; Stenstrom S; Richelson E Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089 [TBL] [Abstract][Full Text] [Related]
9. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related]
10. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550 [TBL] [Abstract][Full Text] [Related]
11. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. Thompson AK; Fisher SK J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059 [TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum. James MK; Cubeddu LX J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384 [TBL] [Abstract][Full Text] [Related]
14. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W; Wolfe BB Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [TBL] [Abstract][Full Text] [Related]
15. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex. Ek B; Antonsson BM Acta Physiol Scand; 1993 Mar; 147(3):289-95. PubMed ID: 8386426 [TBL] [Abstract][Full Text] [Related]
16. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Forray C; el-Fakahany EE Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015 [TBL] [Abstract][Full Text] [Related]
17. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. Balduini W; Murphy SD; Costa LG J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215 [TBL] [Abstract][Full Text] [Related]
18. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation. Meeker RB; Harden TK Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648 [TBL] [Abstract][Full Text] [Related]
19. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line. Bencherif M; Lukas RJ J Pharmacol Exp Ther; 1991 Jun; 257(3):946-53. PubMed ID: 1646330 [TBL] [Abstract][Full Text] [Related]
20. M2 muscarinic receptor subtype is associated with inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris. Akhtar RA; Honkanen RE; Howe PH; Abdel-Latif AA J Pharmacol Exp Ther; 1987 Nov; 243(2):624-32. PubMed ID: 3500300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]